Viraday Tablet

About Viraday Tablet

Viraday Tablet is an innovative combination therapy that incorporates three potent antiretroviral agents: emtricitabine, tenofovir disoproxil fumarate, and efavirenz. This medication is specifically designed for the effective management of Human Immunodeficiency Virus (HIV) type-1 in both adults and adolescents aged 12 years and older, who weigh at least 40 kg. By targeting the virus at multiple stages of its lifecycle, Viraday helps to suppress viral replication, thereby controlling the progression of HIV and reducing the risk of developing acquired immunodeficiency syndrome (AIDS). While generally well-tolerated, patients should be aware of potential side effects, including dizziness and sleep disturbances, and must consult their healthcare provider regarding any pre-existing conditions or concurrent medications. Regular monitoring of kidney function and liver enzymes is advised during treatment with Viraday. This comprehensive approach not only enhances patient outcomes but also empowers individuals living with HIV to lead healthier lives. If you're seeking an effective solution for HIV management, Viraday Tablet could be a valuable addition to your treatment plan. Always discuss your options with a healthcare professional to ensure safe and effective use.